PE-Backed MedPharm Merges With CDMO Tergus Pharma
MedPharm, an Ampersand Capital Partners portfolio company, announced on July 8 a merger with Tergus Pharma, backed by Great Point Partners. The combined organization will operate under the MedPharm name, establishing a leading, end-to-end contract development and manufacturing organization (CDMO) with robust scientific, clinical trial manufacturing and commercial production capabilities. Tergus Pharma is a CDMO that provides formulation development, in vitro permeating testing, in vitro release testing, skin biology, analytical services and clinical manufacturing services for branded and generic dermatology products. MedPharm is an end-to-end contract service provider of topical and... Read More »
HiRO Acquires DeltaMed Solutions, Continues to Expand U.S. Footprint
Harvest Integrated Research Organization (HiRO), has announced the successful acquisition of DeltaMed Solutions, headquartered in Somerset, New Jersey. The acquisition, advised by Evercore as financial advisor, marks HiRO’s third CRO acquisition since its establishment in 2020. DeltaMed Solutions is a global life sciences contract research organization (CRO) with a global footprint in the United States and China. DeltaMed Solutions, headquartered in New Jersey, boasts a team of industry professionals with 15-30 years of expertise in serving large to mid-sized pharmaceutical and biotechs. HiRO is a globally oriented CRO with its headquarters in Shanghai, China. With global operations... Read More »
Walgreens to Reduce Stake in VillageMD
Walgreens Boots Alliance Inc. announced its plan to reduce its majority stake in the primary care provider VillageMD, marking a strategic pivot in its healthcare services approach. This decision, revealed during the company’s third-quarter earnings call on June 27, 2024, comes after significant investments and expansions in the healthcare sector over recent years. In a statement, CEO Tim Wentworth emphasized that while Walgreens remains committed to VillageMD, it will no longer hold the majority ownership. “We believe in the future of these businesses and intend to remain an investor and partner,” Wentworth stated. “But as part of our persistent focus on value creation... Read More »
Sendero Capital & TPG Angelo Gordon acquire Wellesley, MA Medical Outpatient Building
Sendero Capital and TPG Angelo Gordon announced a joint venture to acquire a Wellesley, Massachusetts medical outpatient building (MOB) for $24.3 million. Newmark arranged the transaction. The building, anchored by Mass General Brigham and Tufts Medicine, spans 67,264 square feet and serves various medical specialties. The price is approximately $361 per square foot. Sendero Capital is a privately held real estate investment, development and advisory firm based in Boston, Massachusetts. The principals of the firm have decades of experience investing in, developing and managing large portfolios of real estate across the United States, including millions of square feet in... Read More »
Miami Lakes Medical Outpatient Building Sold to Private Buyer
On June 16, it was announced that a Miami Lakes, Florida medical outpatient building (MOB) was sold to a private buyer. The buyer was Kester Nedd, MD. The MOB is a three-story, 52,122-square-foot facility whose tenants are a variety of healthcare providers. The price is approximately $288 per square foot. The original press release disclosed that there is currently 9,075 square feet of space available for lease in the building. According to data captured in the LevinPro HC database, this transaction marks the 93rd MOB acquisition of 2024. Additionally, this is the 16th MOB in Florida to be acquired this year. Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
